"Hospital privado com emergência 24h, internação em apartamentos, leitos de semi-intensiva, UTI, Centro Cirúrgico e Hemodinâmica. Presta atendimento em Cardiologia, Pneumologia, Ortopedia, Neurologia, Vascular, Cirurgia Bariátrica, Gastroenterologia, Cirurgia Geral, Cirurgia Oncológica, Urologia. Responsável Técnico: Dr. Eduardo Darzé - CRM 11402 - BA"

During the past decade, Hospital Cárdio Pulmonar conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Cárdio Pulmonar" #1 sponsor was "Eidos Therapeutics, a BridgeBio company" with 2 trials, followed by "Hospital Alemão Oswaldo Cruz" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Hospital Israelita Albert Einstein" with 1 trials sponsored and "Kiniksa Pharmaceuticals, Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Cárdio Pulmonar" #1 collaborator was "Ministry of Health, Brazil" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "EMS S/A" with 1 trials as a collaborator and "George Clinical Pty Ltd" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Cárdio Pulmonar" are "COVID-19" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute MI" (1 trials), "Amyloid Cardiomyopathy" (1 trials) and "Amyloidosis" (1 trials). Many other conditions were trialed in "Hospital Cárdio Pulmonar" in a lesser frequency.

Most popular intervention types in "Hospital Cárdio Pulmonar" are "Drug" (7 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Acoramidis (AG10)" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Cárdio Pulmonar" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Cárdio Pulmonar". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Hospital Cárdio Pulmonar, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Cárdio Pulmonar, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".